Amwill Health Care (BOM:544353) EBIT: ₹124.5 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544353 Amwill Health Care Ltd BOM:544353
42 GF Score
Price ₹43.24
! 3 Warning Signs
View Full Analysis

What is Amwill Health Care EBIT?

Amwill Health Care BOM:544353 +1.18% 42 EBIT is ₹124.5 Mil as of Mar. 2026. GuruFocus rates BOM:544353 with a GF Score™ of 42/100. The stock has 3 warning signs investors should review.

Amwill Health Care's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2026 was ₹85.8 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹124.5 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Amwill Health Care's annualized ROC % for the quarter that ended in Mar. 2026 was 26.13%. Amwill Health Care's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 97.18%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Amwill Health Care's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 17.09%.

Amwill Health Care  (BOM:544353) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Amwill Health Care's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=171.62 * ( 1 - 25.29% )/( (633.167 + 348.045)/ 2 )
=128.217302/490.606
=26.13 %

where

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=780.275 - 30.051 - ( 117.057 - max(0, 46.06 - 337.646+117.057))
=633.167

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=866.703 - 44.939 - ( 473.719 - max(0, 57.945 - 718.029+473.719))
=348.045

Note: The Operating Income data used here is two times the semi-annual (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Amwill Health Care's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=171.62/( ( (12.502 + max(146.09, 0)) + (10.944 + max(183.661, 0)) )/ 2 )
=171.62/( ( 158.592 + 194.605 )/ 2 )
=171.62/176.5985
=97.18 %

where Working Capital is:

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(178.797 + 11.368 + 1.985) - (30.051 + 0 + 16.009)
=146.09

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(209.012 + 8.295 + 24.299) - (44.939 + 0 + 13.006)
=183.661

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Amwill Health Care's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=124.47/728.336
=17.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amwill Health Care EBIT Related Terms

Amwill Health Care EBIT Historical Data

* Premium members only.

The historical data trend for Amwill Health Care's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amwill Health Care EBIT Chart

Amwill Health Care Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial 38.31 41.53 164.73 113.26 125.59

Amwill Health Care Semi-Annual Data
Mar21 Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
EBIT Get a 7-Day Free Trial 0.00 86.57 25.39 38.66 85.81

BOM:544353 vs MCK, COR, CAH: EBIT Comparison

For the Medical Distribution subindustry, Amwill Health Care's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amwill Health Care EV-to-EBIT vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Amwill Health Care's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Amwill Health Care's EV-to-EBIT falls into.


BOM:544353
42GF Score
Amwill Health Care Ltd BOM:544353
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Amwill Health Care EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹124.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹124.5 Mil mean?
Amwill Health Care (BOM:544353) has a EBIT of ₹124.5 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Amwill Health Care.
Is Amwill Health Care's EBIT too high?
Amwill Health Care's current EBIT is ₹124.5 Mil. Overall, Amwill Health Care has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Amwill Health Care's EBIT compare to MCK and COR?
Amwill Health Care's EBIT of ₹124.5 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Distribution company?
A good EBIT depends on the Medical Distribution industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Amwill Health Care. Amwill Health Care's current EBIT is ₹124.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amwill Health Care stock overvalued right now?
Amwill Health Care (BOM:544353) has a current EBIT of ₹124.5 Mil. The current EBIT is ₹124.5 Mil. Amwill Health Care's overall GF Score™ is 42/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Amwill Health Care (BOM:544353), the current EBIT is ₹124.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Amwill Health Care Business Description

Address 2nd Main Road, No. 90, 4th Floor, 7th Cross, Chamrajpet, Bangalore, KA, IND, 560 018
Amwill Health Care Ltd is a derma-cosmetic development company. Its focus is on development of problem solving dermatological, cosmeceutical and aesthetical products. The product portfolio is divided into two categories, namely, development and contract manufacturing of generic dermatological solutions; and developing and formulating solutions to specific The company operates in only one segment which is dealing in pharma products.
42GF Score

Get the complete analysis for BOM:544353

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹43.24
Price